Stock KROS KEROS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Keros Therapeutics, Inc.

Equities

KROS

US4923271013

Real-time Estimate Cboe BZX
Other stock markets
 01:57:25 2024-06-04 pm EDT 		5-day change 1st Jan Change
51.12 USD +5.02% Intraday chart for Keros Therapeutics, Inc. +5.01% +28.75%
May. 28 Keros Therapeutics, Inc. Appoints Jean-Jacques Bienaimé to Its Board of Directors and to Serve as A Member of the Nominating Committee, Effective June 1, 2024 CI
May. 08 Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
KEROS THERAPEUTICS, INC.
Bio Therapeutic Drugs
+4.93%+5.01%+28.75%+3.46% - 1.76B
Bearish
Bullish
Bullish
  1. Stock Market
  2. Equities
  3. KROS Stock
  4. Charts Keros Therapeutics, Inc.
  5. Relative Strength Chart